BOCA RATON, Fla.--(BUSINESS WIRE)--Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis has today announced that it has scheduled a shareholder conference call for today at 4:00PM EST to further explain the Company’s recent news and continued progress. The call will feature a presentation by Rik J. Deitsch, Chairman and CEO of Nutra Pharma, along with presentations by Stewart Lonky, MD, a Director of the Company, and Neil Roth, President of Designer Diagnostics. The presentations will be followed by a 15 minute question and answer session.
